Inex Pharmaceuticals Corp (IEX.TO) Buy, Sell…

Home

Daily Stock Opinions and Ratings

Inex Pharmaceuticals Corp (IEX.TO)

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

0.00

-0.00 (0.00%)

0 watching

COMMENT

This is a penny stock and they tend to be promoted.

BUY

A well-run company. Probably one of the lower risk biotech investments in Canada. Their product Onco TCS should be approved this year. Have a good marketing partnership with Enzon.

BUY

If you like biotechs, this could be OK. Speculative.

DON'T BUY

Need to get FDA approval. Too speculative for their funds.

HOLD

Good cash balance. Their problemsare delays in getting their product to market. Needs a good partner.

BUY

Needs approval by FDA. Nice cash balance.

DON'T BUY

There will be some delay in their filings with FDA.

WEAK BUY

In phase 3 trials. Speculative.

PAST TOP PICK

(Was a top pick on Dec 5 no change) Still likes.

TOP PICK

A speculative choice, but has a good RISK/RETURN.

BUY

Just partnered which is good. Good company

Showing 1 to 11 of 11 entries

Inex Pharmaceuticals Corp (IEX.TO) Frequently Asked Questions

What is Inex Pharmaceuticals Corp stock symbol?

Inex Pharmaceuticals Corp is a OTC stock, trading under the symbol IEX.TO (previously IEX-T on Stockchase) on the undefined (undefined). It is usually referred to as or IEX.TO

Is Inex Pharmaceuticals Corp a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on IEX.TO (previously IEX-T on Stockchase) on Stockchase. Read the latest expert commentary for Inex Pharmaceuticals Corp.

Is Inex Pharmaceuticals Corp a good investment or a top pick?

Inex Pharmaceuticals Corp was recommended as a Top Pick by Malvin Spooner on 2001-05-04. Read the latest stock experts ratings for Inex Pharmaceuticals Corp.

Why is Inex Pharmaceuticals Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Inex Pharmaceuticals Corp.

Is Inex Pharmaceuticals Corp worth watching?

Inex Pharmaceuticals Corp is covered by Stockchase experts and is worth watching.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Inex Pharmaceuticals Corp (IEX.TO)